David Grannas

Karolinska Institutet

Papers

1

Total Citations

9

H-Index

1

About

David Grannas is a leading urologic oncologist whose research focuses on improving surgical outcomes for prostate cancer patients, particularly through robot-assisted radical prostatectomy (RARP). His major contributions center on understanding how positive surgical margins (PSMs) affect prognosis across different risk groups. In his highly cited 2025 study, Grannas evaluated the impact of PSMs on biochemical recurrence (BCR) and the need for additional treatment, stratifying patients by the Cancer of the Prostate Risk Assessment (CAPRA) system. This work provides critical guidance for surgeons and patients, demonstrating that the clinical significance of a PSM varies by preoperative risk category. With 9 citations already, this paper is shaping postoperative management strategies. Grannas’s research bridges surgical technique and risk-adapted oncology, helping to refine treatment decisions and reduce overtreatment. His work is essential reading for urologists and researchers seeking to optimize outcomes in prostate cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Positive surgical margin and oncological outcomes after robot‐assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups
9 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Karolinska Institutet

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago